Medesthetics

MAY-JUN 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/970743

Contents of this Issue

Navigation

Page 62 of 68

60 MAY/JUNE 2018 | Med Esthetics MYLAN AND REVANCE PARTNER ON NEW NEUROTOXIN A new neurotoxin may soon be heading to the United States. Phar- maceutical company Mylan has entered into a global collaboration and license agreement with Revance Therapeutics for the develop- ment and commercialization of a biosimilar to Allergan's BOTOX (onabotulinumtoxinA). The companies plan to work together to gain regulatory approval of the product and commercialize it in the U.S., Europe and other markets throughout the world. Mylan will make a $25 million upfront payment to Revance, with contingent milestone payments upon achievement of additional clinical, regulatory and sales targets, plus sales royalties in all relevant markets. ASA ANNOUNCES GRANT WINNERS On March 7, the American Skin Associa- tion (ASA) announced the funding of 13 new research grants for 2018. The ASA awards research grants each year to estab- lished investigators studying melanoma, non-melanoma skin cancer and skin diseases. The 2018 recipients include: Carolyn Lee, MD, PhD, Stanford University ASA Milstein Research Scholar Award in Melanoma/Non-Melanoma Skin Cancer for "Non-Coding Driver Mutations in High-Risk Skin Cancer" Jonathan Zippin, MD, Joan & Sanford I. Weill Cornell Medical College of Cornell University ASA Calder Research Scholar Award Vitiligo/Pigment Cell Disor- ders for "Novel cAMP Signaling Pathway Regulates Melanosome pH and Pigmentation" David Miller, MD, PhD, Massachusetts General Hospital ASA Research Grant for Skin Cancer and Melanoma for "JAK1 Inhibition to Overcome BR AF/MEK Inhibitor Resistance In V600- BR AF Mutant Melanoma" Mayumi Ito, PhD, New York University School of Medicine ASA Mulvaney Family Foundation Research Grant for Vitiligo and Pigment Cell Disorders for "Understanding Mechanisms for Melano- cyte Regeneration Through Stem Cell Biology" Gwennaelle Monnot, PhD, Columbia University Medical Center ASA Research Grant for Psoriasis/Infl ammatory Skin Diseases for "Identifi cation of Pathogenic T Cell Receptor Chains in Alopecia Areata Using Single Cell Sequencing" Howa Yeung, MD, Emory University School of Medicine ASA Research Grant for Quality of Life/Health Services/Outcome Studies for "Quality of Life Impact from Cutaneous Toxicity of Immu- notherapy for Melanoma" Bryan Sun, MD, PhD, University of California, San Diego ASA Research Grant for Childhood Skin Diseases/Disfi gurement for "Impact of Becker's Nevus-Associated ACTB Mutations on Hedgehog Signaling" The following researchers were awarded ASA Hambrick Medical Student Grants for Research Targeting Melanoma and Skin Cancer: Mack Su, Massachusetts General Hospital; Nicole Urman, Stanford University; Albert Young, University of California, San Francisco; Aubriana McEvoy, University of Washington; Khiem Tran, University of Arizona College of Medicine; Todd Wechter, New York University School of Medicine. To apply for future grants, visit americanskin.org. ALASTIN WELCOMES NEW BOARD MEMBERS ALASTIN Skincare has appointed Ann Rhoads and Elisabeth San- doval to the company's Board of Directors. Rhoads is a healthcare fi nance executive with more than 25 years of experience. Sandoval currently serves as chief commercial offi cer for Alder Biopharma- ceuticals, and previously was chief commercial offi cer at Kythera Biopharmaceuticals and VP of global strategic marketing at Allergan. "We are extremely pleased to have Ann and Elisabeth join the ALASTIN team," said Diane S. Goostree, president and CEO of ALASTIN Skincare. "They bring a wealth of experience related to fi nancial and commercialization strategies within the healthcare and aesthetics space and will be valuable advisors to us as we continue our rapid growth and evolution in the aesthetics fi eld.Ó THERMI LAUNCHES NEW PLATFORMS FOR CLINICAL EDUCATION In an effort to help its customers achieve optimal outcomes and spur innovation for future product development, Thermi, a developer of radiofrequency-based devices for skin tightening and fat reduction, has launched two new clinical training initiatives. In 2018, the company is introducing 36 National Centers of Excellence in which new, existing and prospective customers can observe and work with experienced Thermi providers. The clinicians span multiple specialties, including plastic and facial plastic surgery, dermatology, gynecology and uro- gynecology, and the centers will serve as hubs of clinical experience, protocol development and future product development. In addition, the company has launched the Thermi P.R.E.P. (Premier Radiofrequency Expert Platform) National Academy. The academy includes peer-to-peer events at its Centers of Excellence as well as clinical exchange webinars, strategic practice building symposiums and upgraded customer-only web portals with resources and materials. For more information, visit thermi.com. SOCIETY SHIFTS FUE TERMINOLOGY The International Society of Hair Restoration Surgery (ISHRS) is changing its terminology of the hair transplantation method known as FUE from Follicular Unit Extraction to Follicular Unit Excision in an effort to clarify the surgical aspect of the procedure. "The purpose of clarifying that surgical graft removal with FUE in- volves excisions of hair and tissue is to make this terminology more scientifi cally, clinically and surgically accurate," said Ricardo Mejia, MD, ISHRS board member and chair of the ad hoc committee on issues pertaining to the unlicensed practice of medicine. "When NEWS & EVENTS Carolyn Lee, MD, PhD

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - MAY-JUN 2018